A clinic manager loves your scheduling tool in the demo. Six weeks later you're answering a security questionnaire, a clinical safety review and a data protection assessment, and the person who loved the demo has no say in any of them. That's normal. Health buyers are careful because the cost of a bad tool lands on patients.
The founders who cope best treat evidence, compliance and procurement as projects with owners and dates, not as interruptions to the real work. This page covers how to run those projects, which parts a startup workspace like Nautis can hold, and the hard line around patient data.
What makes healthtech startup operations different
Three differences change your plan, your hiring and your runway. Get any of them wrong and the cost shows up a year later.
The software itself may be regulated
The FDA focuses its oversight on device software functions that present a greater risk to patients if they don't work as intended, such as apps that diagnose heart rhythm problems. For some low-risk functions that still meet the device definition, like helping patients self-manage a condition without specific treatment suggestions, it says it won't expect a premarket review. Which side you fall on decides whether you need a quality system and a submission before you sell.
Privacy rules follow the data
Providers and their vendors work under health privacy law. Many consumer health apps and connected devices sit outside it, yet the FTC says makers of those products must comply with its Health Breach Notification Rule. A breach there isn't limited to hacking. Affected people must be told within 60 calendar days, the FTC too when 500 or more are affected, and each violation can bring a civil penalty of up to $53,088.
Buyers check before they buy
In England, NHS adopters review a supplier's completed Digital Technology Assessment Criteria during procurement. It covers clinical safety, data protection, technical assurance, interoperability, and usability and accessibility. The guidance says it isn't legally required but calls it an essential activity. Other countries and large US health systems run their own versions of the same review.
Where each healthtech job lives
| Need | Why it's harder in health | Nautis | Specialist tool |
|---|---|---|---|
| Regulatory route | Device or not decides your whole roadmap | Decision Loop entry, GTM Planner risks | Regulatory consultant, quality management system |
| Provider and payer sales | Many approvers, long cycles | Leads CRM pipelines per buyer type, Forecast panel | None needed early. A larger CRM later |
| Procurement packs | Security, privacy and safety reviews | A data room per buyer with a passcode link | Your security and privacy advisers |
| Clinical evidence | Pilots and studies take quarters | Task Boards, GTM experiments | Research data platform, study management tools |
| Patient data | Strict rules and breach duties | Nothing. Keep it out | EHR or clinical-grade data platform |
| Runway | Revenue arrives late and lumpy | Startup Health, Financial Planner | Accounting software |
| Fundraising | Investors ask for evidence and a regulatory plan | Investor Readiness, Fundraising CRM, data rooms | Your lawyer for the closing documents |
Is your app a medical device?
Answer it on purpose, early, with a regulatory specialist, because the honest answer depends on what the software does and claims, not on what you call it. A wellness app that starts suggesting treatment can move into a different category with one new feature.
Record the answer as a decision. In the Decision Loop, log something like "Position v1 as patient self-management, not diagnosis", category Product, with Reversible? off and a 90-day review. Under Key assumptions, write the claims you will never make in marketing. Then add the same item in the GTM Planner's Risks section, impact High, type Technical, with the mitigation: every new feature and every landing page claim gets a regulatory check before release.
This is where a lot of health startups slip. The product team stays inside the line and the marketing copy crosses it. Keeping the rule in the GTM strategy, next to positioning and messaging, puts it in front of the people who write the copy.
How do you sell to hospitals and clinics?
Expect several buyers in one deal, and give each kind its own pipeline. A clinical champion wants outcomes, IT wants integration and security, finance wants a business case and procurement wants paperwork. In the Leads CRM, a pipeline for health systems might run Champion, Pilot agreed, Security and privacy review, Clinical safety review, Procurement, Contract. Clinics, payers and employers each get their own pipeline, since their stages differ.
Set realistic Expected Close Dates, even when they're three quarters out, so the Forecast panel tells you the truth. Use a custom field for the review status, and an automation rule that raises priority when a deal reaches procurement.
Build one procurement pack and reuse it. A data room per buyer holds your security answers, clinical safety summary, data protection assessment and assessment criteria responses, shared by private link with an expiry. These are documents about your company and product. None of them should contain patient information.
One note on pace. Rock Health's 2025 year-end funding report says sales cycles are shortening in healthcare AI, citing an outside source. Enjoy it if it happens to you, but don't build a runway plan on it.
Running clinical evidence like a product launch
Buyers and investors both ask the same question in different words: does it work for patients? A pilot that ends with a usage chart rarely answers it. Decide the outcome measure before the pilot starts and write it down.
The GTM Planner's Experiments tab suits this. Write the hypothesis in its own format, for example "If two clinics use automated reminders for 90 days, we expect missed appointments to fall because patients confirm by text", pick the metric and track status through Testing to Won, Lost or Learnings. Put the study's practical work, such as ethics paperwork, site agreements and data exports, on a task board with owners and due dates.
Keep the study data itself in the research or clinical system it was collected in. What goes into Nautis is the summary: the protocol, the headline result and the slide you'll show investors.
Pilot fees need care in Startup Health too. The guide says to count recurring revenue only and treat one-off project revenue as cash. A paid pilot is one-off until it converts, so leave it out of MRR or your growth chart will lie to you.
Keeping patient data out of Nautis
Nautis holds no certification for health data, and it isn't a clinical system. Make this a written rule for the whole team, including contractors.
- No patient records, test results or clinical notes in notes, sheets, data rooms or task comments.
- No patient intake through Custom forms. Use forms for demo requests, waitlists or clinician feedback that names no patients.
- Think before connecting an inbox. If a mailbox receives messages from patients, don't connect it to Nautis. Use one that only handles company business.
- Watch meeting transcripts. If a call with a clinic discusses individual patients, don't sync that transcript into a meeting record.
- Don't paste patient details into AI chats. Describe the problem in general terms instead.
If something slips through, treat it as an incident and talk to your privacy adviser. The FTC's point that a breach isn't limited to cyber intrusions is a useful reminder that an unauthorised disclosure can be as simple as data in the wrong place.
Raising money for a health startup
Rock Health counted $14.2 billion raised by US digital health startups across 482 deals in 2025, with an average deal of $29.3 million. AI-enabled companies took 54% of the money. It also warned the year was a tale of haves and have-nots: remove the top nine companies and total funding falls below 2024.
For most founders that means the bar is evidence. Investor Readiness scores your data room against the diligence list for your stage and builds an action plan, and its Investor lens lists likely objections so you can prepare answers. For a health company, expect objections about regulatory route, reimbursement and evidence. In Find Investors, filter by Industries to build a list of funds that already back health, then work the round in the Fundraising CRM.
When Nautis isn't the right fit for healthtech
- You need a quality management system for device software. Design controls, document control and complaint handling for a regulated device need dedicated tooling.
- You need anything that stores or processes patient data. That's your clinical platform's job, not a company workspace's.
- A buyer requires certification from every vendor in your stack. Ask Nautis what it can provide, and don't assume any certification.
- You're a large health organisation. Complex permissions and mature processes usually fit enterprise tools better.
- You need years of independent reviews. Nautis launched publicly in July 2026.
FAQ
What does healthtech startup operations software need to cover?
It should cover the company side: provider pipelines with long close dates, procurement packs, evidence projects, runway and investor diligence. It should never be where patient data lives. Clinical records, study data and patient messages belong in clinical-grade systems chosen with your privacy adviser.
Can I use Nautis to store patient information?
No. Nautis holds no certification for health data and isn't a clinical system. Keep patient records, results and messages in your EHR or clinical data platform, and don't paste them into notes, forms or AI chats.
How long does it take to sell to a hospital?
Long enough that you should plan runway around it. Several groups review a purchase, often clinical, IT, privacy and procurement, and a pilot usually comes first. Track each stage in its own pipeline, set honest close dates and reuse one procurement pack.
Do health apps outside health privacy law have breach duties?
In the US, many do. The FTC says makers of health apps, connected devices and similar products must comply with its Health Breach Notification Rule. That includes notifying affected people within 60 calendar days of discovering a breach.